Feature

Survey: Americans support regulation of vaping products


 

Almost 70% of adults believe that the Food and Drug Administration should raise the legal age to purchase e-cigarettes and tobacco, according to a new survey by NORC at the University of Chicago, a nonpartisan research institution.

Visual abstract -- Support for FDA action on e-cigarettes

“Americans are particularly concerned about teens becoming newly addicted to e-cigarettes, and they support a range of actions the federal government could take to make vaping products less available, less addictive, and less appealing,” Caroline Pearson, senior vice president at NORC, said in a written statement.

The AmeriSpeak Spotlight on Health Poll, conducted Feb. 14-18, 2019 (margin of error, plus or minus 4.12%), showed that 69% of adults strongly or somewhat support raising the age limit to purchase e-cigarettes and tobacco and 55% support restricting sales of flavored e-cigarettes, NORC reported. Almost 40% of the 1,004 respondents expressed support for a complete ban on e-cigarettes.

Despite FDA efforts under Commissioner Scott Gottlieb, MD, to raise awareness of teen vaping, only 21% of those surveyed correctly responded that e-cigarettes generally contain more nicotine that regular cigarettes. Dr. Gottlieb announced his resignation recently, “but he indicated that the Trump Administration will continue efforts to increase regulation of e-cigarettes,” NORC said.

Recommended Reading

Flu season showing its staying power
Clinician Reviews
TNF inhibitor prices rose despite increased drug class competition
Clinician Reviews
Influenza activity continues to increase
Clinician Reviews
Large survey reveals that few MS patients have long-term care insurance
Clinician Reviews
Flu season shows signs of peaking
Clinician Reviews
Malpractice suits are less frequent – but more costly
Clinician Reviews
New IPF diagnosis test now covered by Medicare
Clinician Reviews
Flu activity down for a second straight week
Clinician Reviews
‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patients
Clinician Reviews
Flu activity levels down, but outpatient visits highest since 1998-99
Clinician Reviews